At what enterprise value was VISION HEALTHCARE acquired in 2020?

During the acquisition of VISION HEALTHCARE by AVISTA CAPITAL PARTNERS in 2020, the company was valued at an estimated revenue multiple of below 5x. The transaction's Enterprise Value is estimated to be in the range of 300M - 700M EUR. By registering for free, you get access to complete and exact transaction details including enterprise value, revenue, and EBITDA. Additionally, our database shows that the Healthcare & Pharma industry currently tracks an average EBITDA multiple of 13.4x, providing a valuable benchmark for this transaction.

What was the EV/EBITDA of VISION HEALTHCARE when it was acquired by AVISTA CAPITAL PARTNERS?

The estimated EV/EBITDA multiple for VISION HEALTHCARE is in the range of 10x - 18x. For comparison, the Healthcare & Pharma sector currently shows an average EBITDA multiple of 13.4x. Join our community for free to access full valuation data and industry trends.

What was the revenue of VISION HEALTHCARE at the time of the deal?

The revenue of VISION HEALTHCARE at the time of the deal is estimated to be in the range of 100M - 200M EUR. Register for free to access the full transaction report and exact valuation multiples.

What was the EBITDA of VISION HEALTHCARE during the acquisition?

VISION HEALTHCARE's EBITDA is estimated to be in the range of 10M - 30M EUR. Join our community for free to access complete and exact deal data.

What is Enterprise Value (EV)?

Enterprise Value (EV) is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. EV includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

What is the EV/EBITDA multiple and why is it used?

The EV/EBITDA multiple is a financial ratio that compares a company's Enterprise Value (EV) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). It is widely used in M&A and valuation because it allows for comparisons between companies with different capital structures and provides a clear view of operational profitability.

How is the data for the VISION HEALTHCARE acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the VISION HEALTHCARE deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://www.avistahealthcare.com/news_item/avista-capital-partners-and-vhc-investco-acquire-vision-healthcare-nv-in-a-transaction-valued-at-336-million/

← DATABASE

Home Database Healthcare & PharmaVISION HEALTHCARE

06/2020

VISION HEALTHCARE

Acquired by

AVISTA CAPITAL PARTNERS

BELGIUM Life Sciences / Nutrition & Dietary Supplements EV 300M - 700M EUR

VISION HEALTHCARE acquired by AVISTA CAPITAL PARTNERS

BELGIUM Life Sciences / Nutrition & Dietary Supplements EV 300M - 700M EUR

Context

The acquisition of Vision Healthcare NV by Avista Capital Partners marks a significant milestone in the company's strategic journey. The partnership enables Vision to realize further rapid growth and make additional investments that leverage its differentiated direct-to-consumer business model. With Avista's expertise and resources, Vision is well-positioned to expand its geographic reach and accelerate its acquisition strategy into the global direct-to-consumer healthcare market. The transaction also allows Vision to benefit from Avista's experience in the consumer healthcare sector, providing operational guidance and financial resources to drive growth and performance. As the consumer healthcare market continues to evolve, Vision is poised to take advantage of the growing demand for preventive health solutions and direct-to-consumer experiences, and the partnership with Avista will play a critical role in supporting the company's ambitious growth plans.

VISION HEALTHCARE, which reported an EBITDA margin of LOGIN in 2020, is valued in this transaction at an EV/EBITDA multiple of LOGIN, representing a LOGIN to the average currently observed in the Healthcare & Pharma sector (13.4x).

Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.

-> Deep-dive in Healthcare & Pharma market trends

Target

Vision Healthcare NV is a Belgium-based consumer healthcare platform with sales and operations across continental Europe. The company owns and markets a large branded portfolio of self-care and over-the-counter products, utilizing an omni-channel approach with a specific focus on online and direct-to-consumer channels. Founded in 2017, Vision has rapidly grown through a combination of successful buy-and-build strategies and strong organic growth in its direct-to-consumer businesses. With a strong focus on innovation and customer satisfaction, Vision aims to provide high-quality healthcare products and services to its customers. The company's mission is to become a leading player in the European consumer healthcare market, and it is well-positioned to take advantage of the growing demand for preventive health solutions and direct-to-consumer experiences.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2020

2019

Other operations with VISION HEALTHCARE

REFERENCES

Valuation range: EV 300M - 700M EUR

Revenue range: 100M - 200M EUR

EBITDA range: 10M - 30M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of VISION HEALTHCARE by AVISTA CAPITAL PARTNERS are reserved for mynth community members. Register for free to unlock full data.

Authors: mynth contributor (mynth data is contributed by M&A / PE professionals and systematically cross-verified with private deal documents and official press releases).

Press release: view release

Target: vision healthcare

Acquirer: avista capital partners